# Regional Management Corp.: financial statements, quarterly

RM · NYSE · CIK 1519401 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rm.md) · [Financials](/companies/rm/financials.md) · [Filings](/companies/rm/filings.md) · [Insiders](/companies/rm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [141](/filings/0000950170-24-124156.md) | [142 d](/filings/0001193125-26-061549.md) | [144](/filings/0000950170-25-062837.md) | [143](/filings/0000950170-25-101457.md) | [146](/filings/0001193125-25-269725.md) | [155 d](/filings/0001193125-26-061549.md) | [153](/filings/0001519401-26-000009.md) | [157](/filings/0001519401-26-000015.md) | [165](/filings/0001193125-25-269725.md) | [170 d](/filings/0001193125-26-061549.md) | [167](/filings/0001519401-26-000009.md) | [168](/filings/0001519401-26-000015.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.1](/filings/0000950170-24-124156.md) | [(2.0) d](/filings/0001193125-26-061549.md) | [4.7](/filings/0000950170-25-062837.md) | [2.8](/filings/0000950170-25-101457.md) | [2.5](/filings/0001193125-25-269725.md) | [2.8 d](/filings/0001193125-26-061549.md) | [2.2](/filings/0001519401-26-000009.md) | [3.3](/filings/0001519401-26-000015.md) | [4.6](/filings/0001193125-25-269725.md) | [3.2 d](/filings/0001193125-26-061549.md) | [3.4](/filings/0001519401-26-000009.md) | [2.4](/filings/0001519401-26-000015.md) |
| Net income | $m | [8.8](/filings/0000950170-24-124156.md) | [(7.6) d](/filings/0001193125-26-061549.md) | [15.2](/filings/0000950170-25-062837.md) | [8.4](/filings/0000950170-25-101457.md) | [7.7](/filings/0001193125-25-269725.md) | [9.9 d](/filings/0001193125-26-061549.md) | [7.0](/filings/0001519401-26-000009.md) | [10.1](/filings/0001519401-26-000015.md) | [14.4](/filings/0001193125-25-269725.md) | [12.9 d](/filings/0001193125-26-061549.md) | [11.4](/filings/0001519401-26-000009.md) | [8.2](/filings/0001519401-26-000015.md) |
| Diluted EPS | $ per share | [0.91](/filings/0000950170-24-124156.md) | not reported | [1.56](/filings/0000950170-25-062837.md) | [0.86](/filings/0000950170-25-101457.md) | [0.76](/filings/0001193125-25-269725.md) | not reported | [0.70](/filings/0001519401-26-000009.md) | [1.03](/filings/0001519401-26-000015.md) | [1.42](/filings/0001193125-25-269725.md) | not reported | [1.18](/filings/0001519401-26-000009.md) | [0.85](/filings/0001519401-26-000015.md) |
| Basic EPS | $ per share | [0.94](/filings/0000950170-24-124156.md) | not reported | [1.59](/filings/0000950170-25-062837.md) | [0.88](/filings/0000950170-25-101457.md) | [0.79](/filings/0001193125-25-269725.md) | not reported | [0.73](/filings/0001519401-26-000009.md) | [1.07](/filings/0001519401-26-000015.md) | [1.53](/filings/0001193125-25-269725.md) | not reported | [1.24](/filings/0001519401-26-000009.md) | [0.91](/filings/0001519401-26-000015.md) |

- Revenue: us-gaap:Revenues
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.4](/filings/0000950170-24-124156.md) | [4.5](/filings/0001193125-26-061549.md) | [4.2](/filings/0000950170-25-062837.md) | [4.3](/filings/0000950170-25-101457.md) | [4.7](/filings/0001193125-25-269725.md) | [4.0](/filings/0001193125-26-061549.md) | [4.2](/filings/0001519401-26-000009.md) | [4.3](/filings/0001519401-26-000015.md) | [4.1](/filings/0001193125-25-269725.md) | [3.8](/filings/0001519401-26-000015.md) | [4.9](/filings/0001519401-26-000009.md) | [6.8](/filings/0001519401-26-000015.md) |
| Total assets | $m | [1,765](/filings/0000950170-23-058861.md) | [1,795](/filings/0000950170-25-024903.md) | [1,900](/filings/0000950170-25-062837.md) | [1,789](/filings/0000950170-24-090023.md) | [1,822](/filings/0000950170-24-124156.md) | [1,909](/filings/0001193125-26-061549.md) | [1,901](/filings/0000950170-25-062837.md) | [1,967](/filings/0000950170-25-101457.md) | [2,028](/filings/0001193125-25-269725.md) | [2,104](/filings/0001519401-26-000015.md) | [2,073](/filings/0001519401-26-000009.md) | [2,130](/filings/0001519401-26-000015.md) |
| Total liabilities | $m | [1,435](/filings/0000950170-23-058861.md) | [1,472](/filings/0000950170-25-024903.md) | [1,420](/filings/0000950170-24-052963.md) | [1,444](/filings/0000950170-24-090023.md) | [1,469](/filings/0000950170-24-124156.md) | [1,552](/filings/0001193125-26-061549.md) | [1,543](/filings/0000950170-25-062837.md) | [1,604](/filings/0000950170-25-101457.md) | [1,656](/filings/0001193125-25-269725.md) | [1,731](/filings/0001519401-26-000015.md) | [1,697](/filings/0001519401-26-000009.md) | [1,751](/filings/0001519401-26-000015.md) |
| Long-term debt | $m | [1,367](/filings/0000950170-23-058861.md) | [1,395](/filings/0000950170-25-024903.md) | [1,355](/filings/0000950170-24-052963.md) | [1,373](/filings/0000950170-24-090023.md) | [1,391](/filings/0000950170-24-124156.md) | [1,472](/filings/0001193125-26-061549.md) | [1,470](/filings/0000950170-25-062837.md) | [1,502](/filings/0000950170-25-101457.md) | [1,574](/filings/0001193125-25-269725.md) | [1,642](/filings/0001519401-26-000015.md) | [1,614](/filings/0001519401-26-000009.md) | [1,670](/filings/0001519401-26-000015.md) |
| Shareholders' equity | $m | [331](/filings/0000950170-24-124156.md) | [322](/filings/0001193125-26-061549.md) | [336](/filings/0000950170-25-101457.md) | [345](/filings/0001193125-25-269725.md) | [353](/filings/0001193125-25-269725.md) | [357](/filings/0001519401-26-000015.md) | [358](/filings/0001519401-26-000015.md) | [363](/filings/0001519401-26-000015.md) | [372](/filings/0001193125-25-269725.md) | [373](/filings/0001519401-26-000015.md) | [376](/filings/0001519401-26-000015.md) | [378](/filings/0001519401-26-000015.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [67.5 d](/filings/0000950170-24-124156.md) | [66.9 d](/filings/0001193125-26-061549.md) | [58.5](/filings/0000950170-25-062837.md) | [71.5 d](/filings/0000950170-25-101457.md) | [75.1 d](/filings/0001193125-25-269725.md) | [63.8 d](/filings/0001193125-26-061549.md) | [63.7](/filings/0001519401-26-000009.md) | [78.7 d](/filings/0001519401-26-000015.md) | [86.7 d](/filings/0001193125-25-269725.md) | [80.1 d](/filings/0001193125-26-061549.md) | [81.0](/filings/0001519401-26-000009.md) | [80.8 d](/filings/0001519401-26-000015.md) |
| Capital expenditure | $m | [0.8 d](/filings/0000950170-24-124156.md) | [1.1 d](/filings/0001193125-26-061549.md) | [1.0](/filings/0000950170-25-062837.md) | [1.2 d](/filings/0000950170-25-101457.md) | [1.3 d](/filings/0001193125-25-269725.md) | [1.5 d](/filings/0001193125-26-061549.md) | [1.3](/filings/0001519401-26-000009.md) | [1.0 d](/filings/0001519401-26-000015.md) | [1.0 d](/filings/0001193125-25-269725.md) | [1.5 d](/filings/0001193125-26-061549.md) | [1.1](/filings/0001519401-26-000009.md) | [1.5 d](/filings/0001519401-26-000015.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [6.5](/filings/0001519401-26-000009.md) | [5.0 d](/filings/0001519401-26-000015.md) | [5.0 d](/filings/0001193125-25-269725.md) | [7.5 d](/filings/0001193125-26-061549.md) | [7.5](/filings/0001519401-26-000009.md) | [5.1 d](/filings/0001519401-26-000015.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.5](/filings/0000950170-23-058861.md) | [9.6](/filings/0000950170-24-052963.md) | [9.6](/filings/0000950170-24-090023.md) | [9.7](/filings/0000950170-24-124156.md) | [9.7](/filings/0000950170-25-062837.md) | [9.9](/filings/0000950170-25-101457.md) | [10.1](/filings/0001193125-25-269725.md) | [10.0](/filings/0001519401-26-000009.md) | [9.8](/filings/0001519401-26-000015.md) | [10.1](/filings/0001193125-25-269725.md) | [9.7](/filings/0001519401-26-000009.md) | [9.6](/filings/0001519401-26-000015.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,225,794 at 2026-07-29, from the cover of the [10-Q filed 2026-07-31](/filings/0001519401-26-000015.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.